Cargando…
Treatment of patients with von Willebrand disease
Von Willebrand disease (vWD) is the most common hereditary bleeding disorder. The aim of therapy is to correct the dual hemostatic defect, due to defective platelet adhesion-aggregation and abnormal coagulation due to Factor VIII (FVIII) deficiency. The choice of treatment depends on a number of fac...
Autores principales: | Tuohy, Emma, Litt, Emma, Alikhan, Raza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262353/ https://www.ncbi.nlm.nih.gov/pubmed/22287863 http://dx.doi.org/10.2147/JBM.S9890 |
Ejemplares similares
-
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019) -
Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011) -
Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013) -
Prophylactic management of patients with von Willebrand disease
por: Franchini, Massimo, et al.
Publicado: (2021) -
The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)